LPL Financial Holdings Inc. · LPLA · FY2025 Q4 · Calendar Q1 2026

LPL posts record Q4 EPS as Commonwealth integration shapes the outlook

LPL's Q4 results support a constructive operating picture: organic asset growth and record adjusted EPS coincided with improving operating leverage. The durability of that growth depends on Commonwealth integration and retention, recruiting conversion, and the effect of rate changes on cash-sweep economics.

Reported After market closeNASDAQFinancial Services $22.34B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $5.23 Consensus $4.92
EPS surprise +6.3% Reported versus consensus
Reported revenue $4.93B Consensus $4.91B
Revenue surprise +0.5% Reported versus consensus

Market reaction

event-close to next-session close
Stock move +0.5% Event window
SPY move -0.3% Same window
Abnormal move +0.8% Stock minus SPY
Volume 2.2× Versus trailing sessions
Subsequent drift -16.0% Up to 20 sessions
LPLASPY benchmark

Ask FN2 about LPLA FY2025 Q4

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with Q3 2025, management's analysis points to total assets rising from $2.3 trillion to a record $2.4 trillion and adjusted EPS increasing from $5.20 to $5.23. The Q4 analysis also highlights 8% year-over-year organic asset growth, while Commonwealth integration and its expected EBITDA contribution remain central to the outlook.

Guidance delta

Guidance sentiment was characterized as maintained. The supplied analysis identifies no guidance reset; management expects a $425 million run-rate EBITDA contribution from Commonwealth once integrated, while buybacks remain paused pending the leverage target.

Key takeaways

  • Adjusted EPS of $5.23 exceeded the $4.92 estimate; revenue of about $4.93 billion was modestly above the roughly $4.91 billion estimate.
  • Organic assets grew 8% year over year, and total assets reached a record $2.4 trillion.
  • Management described Commonwealth integration as progressing and cited an expected $425 million run-rate EBITDA contribution once fully integrated.
  • Operating leverage improved, with G&A below the outlook range and pretax margin around 36%, according to the supplied call analysis.

Management priorities

  • Complete Commonwealth integration and implement its target operating model.
  • Convert adviser recruiting activity into net new assets and expand affiliation models.
  • Continue automation, AI and technology work to improve efficiency and client experience.
  • Resume share repurchases only after leverage reaches the stated target.

Follow LPLA with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
LPLA EPS earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q2 '24 estimate $3.70 Q2 '24 actual $3.88, beat Q3 '24 estimate $3.71 Q3 '24 actual $4.16, beat Q2 '25 estimate $4.23 Q2 '25 actual $4.51, beat Q3 '25 estimate $4.49 Q3 '25 actual $5.20, beat Q4 '25 estimate $4.92 Q4 '25 actual $5.23, beat Q1 '26 estimate $5.48 Q1 '26 actual $5.60, beat Q2 '26 estimate $5.39 Q2 '26 actual $5.84, beat Q3 '26 estimate $5.66 Q3 '26 actual $5.97, beat Q4 '26 estimate $6.01 Q1 '27 estimate $7.02 Q2 '27 estimate $7.41 Q3 '27 estimate $7.62
Show 2 more >

Analyst Consensus ?

ConsensusBuy27 ratings
Bullish1659.3%
Neutral1037.0%
Bearish13.7%

1 unmapped firm rating excluded from the percentages.

Analyst 52W Price Targets

$283.74Current
$174Low
$358.86Average
$554High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 2, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
UBS Buy BuyMaintainOct 29, 2026
Wells Fargo Overweight OverweightMaintainOct 28, 2026
Truist Securities Hold HoldMaintainOct 28, 2026
TD Cowen Hold HoldMaintainOct 28, 2026
JP Morgan Overweight OverweightMaintainOct 28, 2026
Barclays Overweight OverweightMaintainOct 28, 2026
Morgan Stanley Overweight OverweightMaintainOct 9, 2026
BMO Capital Outperform OutperformMaintainOct 6, 2026
Citizens Market Outperform Market OutperformMaintainOct 5, 2026
B of A Securities Buy BuyMaintainOct 5, 2026
Keefe, Bruyette & Woods Outperform OutperformMaintainJul 31, 2026
Keefe Bruyette Outperform OutperformMaintainApr 8, 2026
Raymond James Mkt Perform UnderperformUpgradeOct 9, 2025
Rothschild & Co Redburn Neutral BuyDowngradeSep 19, 2025
Citigroup Sell NeutralDowngradeJul 9, 2025
Redburn Atlantic Buy NeutralUpgradeJun 9, 2025
JMP Securities Market Outperform Market OutperformMaintainOct 9, 2024
Jefferies Buy BuyMaintainOct 4, 2024
Goldman Sachs Buy BuyMaintainSep 26, 2024
Credit Suisse Neutral NeutralMaintainApr 28, 2023
Compass Point Neutral BuyDowngradeMay 8, 2019
Bernstein Outperform OutperformMaintainApr 10, 2018
Nomura Buy BuyMaintainFeb 2, 2018
Keefe Bruyette & Woods Market Perform Market PerformMaintainJul 29, 2016
SunTrust Robinson Humphrey Neutral NeutralMaintainJun 2, 2016
Susquehanna Neutral NegativeUpgradeFeb 5, 2016
S&P Capital IQ Hold BuyDowngradeJan 2, 2014
Bank of America Neutral NeutralMaintainFeb 21, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $283.74. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Goldman SachsAlexander Blostein$400$317.56 +41.0%Oct 28, 2026
Truist FinancialAnalyst unavailable$354$323.67 +24.8%Oct 13, 2026
Morgan StanleyAnalyst unavailable$393$328 +38.5%Oct 9, 2026
BarclaysAnalyst unavailable$409$332.39 +44.1%Oct 7, 2026
UBSAnalyst unavailable$390$332.39 +37.4%Oct 7, 2026
Capital One FinancialAnalyst unavailable$370$335.59 +30.4%Oct 6, 2026
OppenheimerAnalyst unavailable$554$316.44 +95.2%Oct 5, 2026
Wells FargoDaniel Welden$362$312.15 +27.6%Oct 1, 2026
Truist FinancialDavid Smith$389$370.14 +37.1%Sep 1, 2026
Wolfe ResearchAnalyst unavailable$454$371.19 +60.0%Aug 12, 2026
BMO CapitalAnalyst unavailable$390$353.7 +37.4%Aug 3, 2026
BarclaysAnalyst unavailable$401$339.17 +41.3%Jul 31, 2026
Morgan StanleyAnalyst unavailable$387$314.31 +36.4%Jul 10, 2026
BarclaysAnalyst unavailable$394$311.41 +38.9%Jul 9, 2026
BarclaysAnalyst unavailable$412$334.13 +45.2%May 1, 2026
Morgan StanleyMichael Cyprys$374$307.94 +31.8%Apr 10, 2026
UBSAnalyst unavailable$500$376.33 +76.2%Feb 3, 2026
Wolfe ResearchAnalyst unavailable$478$362.28 +68.5%Jan 30, 2026
BarclaysBenjamin Budish$434$362.71 +53.0%Jan 30, 2026
BarclaysAnalyst unavailable$444$359.38 +56.5%Jan 8, 2026
Wolfe ResearchAnalyst unavailable$486$365.74 +71.3%Jan 7, 2026
Morgan StanleyAnalyst unavailable$447$362.46 +57.5%Dec 22, 2025
BarclaysAnalyst unavailable$453$387.5 +59.7%Dec 12, 2025
UBSMichael Brown$406$386.99 +43.1%Dec 11, 2025
JMP SecuritiesAnalyst unavailable$475$338.49 +67.4%Oct 31, 2025
BarclaysAnalyst unavailable$420$338.49 +48.0%Oct 31, 2025
Goldman SachsAlexander Blostein$421$338.49 +48.4%Oct 31, 2025
UBSAnalyst unavailable$455$325.13 +60.4%Oct 9, 2025
BarclaysBenjamin Budish$411$317.32 +44.9%Oct 8, 2025
Morgan StanleyAnalyst unavailable$462$323.33 +62.8%Oct 1, 2025
BarclaysAnalyst unavailable$460$362.83 +62.1%Sep 2, 2025
BarclaysBenjamin Budish$379$335.64 +33.6%Jan 13, 2025
Wells FargoMichael Brown$285$245.83 +0.4%Oct 9, 2024
Goldman SachsAlexander Blostein$271$230.35 -4.5%Sep 25, 2024
Bank of America SecuritiesCraig Siegenthaler$268$221.58 -5.5%Jul 30, 2024
JMP SecuritiesDevin Ryan$310$239.2 +9.3%Jul 26, 2024
BarclaysBenjamin Budish$273$239.2 -3.8%Jul 26, 2024
BarclaysBenjamin Budish$313$273.22 +10.3%Jul 10, 2024
JefferiesGerald O'Hara$334$272.66 +17.7%Jul 8, 2024
BarclaysBenjamin Budish$319$269.13 +12.4%May 1, 2024
JMP SecuritiesDevin Ryan$305$261.3 +7.5%Apr 9, 2024
Morgan StanleyMichael Cyprys$315$261.3 +11.0%Apr 9, 2024
UBSAnalyst unavailable$250$216.94 -11.9%Aug 4, 2022
Morgan StanleyAnalyst unavailable$246$191.25 -13.3%Apr 29, 2022
Compass PointChristopher Allen$195$163.51 -31.3%Oct 29, 2021
Wells FargoChristopher Harris$174$155.69 -38.7%Apr 30, 2021
BarclaysJeremy Campbell$175$155.69 -38.3%Apr 30, 2021
Show less

Track every rating change on LPLA the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

LPL Financial Holdings Inc., operating through its subsidiaries, delivers an integrated ecosystem of brokerage and investment advisory solutions. These services are primarily aimed at independent financial professionals and advisors affiliated with financial institutions across the United States. The firm's brokerage division offers a diverse range of financial instruments, encompassing various annuities (both variable and fixed), mutual funds, equities, and savings vehicles for retirement and education. It also includes fixed income products, insurance, and specialized alternative investments such as non-traded real estate investment trusts and auction rate notes.…

Historical context

All LPLA earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the LPLA recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-11-02T00:50:43.485172+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-02T00:50:43.482396+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-11-02. For educational purposes only; not investment advice.